Cyclopropyl piperidine glycine transporter inhibitors

Details for Australian Patent Application No. 2005292323 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Wisnoski, David D.; Wolkenberg, Scott E.; Lindsley, Craig W.

Agent Spruson & Ferguson

Pub. Number AU-B-2005292323

PCT Pub. Number WO2006/039221

Priority 60/614,942 30.09.04 US

Filing date 26 September 2005

Wipo publication date 13 April 2006

Acceptance publication date 9 June 2011

International Classifications

C07D 211/00 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/039221 Priority application(s): WO2006/039221

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

9 June 2011 Application Accepted

  Published as AU-B-2005292323

6 October 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292324-Method and apparatus for virtualizing window information

2005292317-Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)